The most significant change to dining habits among GLP-1 users is that they report eating smaller portion sizes since beginning their medication, which is likely a direct result of the medication acting to suppress appetite
Second, study populations have been heterogeneous with respect to diabetes status, obesity, renal function, baseline cardiovascular disease, and HF phenotype, which may limit generalizability
It is rarely the first hormone discussed in the context of women's health, and its decline during the menopausal transition receives far less clinical attention than the fall in estrogen and progesterone
World Journal of Cardiology
Myth 2: GLP-1 Medications Deliver Instant, Permanent Results GLP-1 medications dont promise instant or permanent weight loss
If not able to eat normally, replace meals with high-carbohydrate snacks or drinks